Neuro Endocrinol Lett. 2006 Aug 5;27(4) [Epub ahead of print]
Mercury toxicity presenting as Chronic Fatigue, memory impairment and depression: Diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006).
Wojcik DP, Godfrey ME, Christie D, Haley BE. Northland Environmental Health Clinic, 2 Dip Rd, Kamo, Whangarei, Northland, New Zealand. This email address is being protected from spambots. You need JavaScript enabled to view it..
In a group of 465 patients diagnosed as having chronic mercury toxicity (CMT), 32.3% had severe fatigue, 88.8% had memory loss, and 27.5% had depression. A significant correlation was found between CMT and the Apo-lipoprotein E4 genotype (p=0.001). An investigation into an additional 864 consecutively seen general practice patients, resulted in 30.3% having evidence consistent with CMT, and once again a significant correlation was found with the APO-E4 genotype (p=0.001). Removal of amalgam mercury fillings when combined with appropriate treatment resulted in a significant symptom reduction (p< 0.001) to levels reported by healthy subjects.
PMID: 16891999 [PubMed - as supplied by publisher]
{mosgoogle}
{mos_sb_discuss:14}
Please Help Support EiR with a Positive Google Review!
If you like EiR and / or enoyed this content; please help us keep going by leaving a Positive Google Review:
Review EiR on Google NOW!
P.S. This is entirely secure, we collect no data other than what is freely available from Google and you can remain anonymous!
Related Articles:
Mold Testing & Sanitizer:
ADVERTISEMENT
